Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
Merck on Thursday reported fourth-quarter revenue and adjusted earnings that topped estimates as it saw strong demand for its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. The pharmaceutical giant posted a net quarterly loss, however, due to previously announced charges associated with a deal the company struck in October with the Japanese drugmaker Daiichi […]
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales Read More »